These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31918593)

  • 1. Drug-coated balloons in cardiovascular disease: benefits, challenges, and clinical applications.
    Nestelberger T; Kaiser C; Jeger R
    Expert Opin Drug Deliv; 2020 Feb; 17(2):201-211. PubMed ID: 31918593
    [No Abstract]   [Full Text] [Related]  

  • 2. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-coated Balloons for Small Coronary Disease-A Literature Review.
    Arslani K; Jeger R
    Curr Cardiol Rep; 2021 Oct; 23(11):173. PubMed ID: 34648080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
    Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the clinical use of drug-coated balloons in percutaneous coronary interventions.
    Cheng Y; Leon MB; Granada JF
    Expert Opin Drug Deliv; 2016 Jun; 13(6):859-72. PubMed ID: 26924794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group.
    Her AY; Shin ES; Bang LH; Nuruddin AA; Tang Q; Hsieh IC; Hsu JC; Kiam OT; Qiu C; Qian J; Ahmad WAW; Ali RM
    Cardiol J; 2021; 28(1):136-149. PubMed ID: 31565793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.
    Tang Y; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Tian J; Guan C; Xu B; Gao R;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2381-2392. PubMed ID: 30522667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery aneurysm formation after drug-coated balloon treatment of de novo lesions: Two case reports.
    Zhang HP; Yu X; Ji FS; Sun FC
    Medicine (Baltimore); 2018 Nov; 97(45):e13208. PubMed ID: 30407362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review.
    Mohiaddin H; Wong TDFK; Burke-Gaffney A; Bogle RG
    Cardiol Ther; 2018 Dec; 7(2):127-149. PubMed ID: 30368735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 15. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial.
    Scheller B; Ohlow MA; Ewen S; Kische S; Rudolph TK; Clever YP; Wagner A; Richter S; El-Garhy M; Böhm M; Degenhardt R; Mahfoud F; Lauer B
    EuroIntervention; 2020 Apr; 15(17):1527-1533. PubMed ID: 31659986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB.
    Meneguz-Moreno RA; Ribamar Costa J; Abizaid A
    Curr Cardiol Rep; 2018 Aug; 20(10):100. PubMed ID: 30171374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review.
    Nestelberger T; Jeger R
    Interv Cardiol; 2019 Nov; 14(3):131-136. PubMed ID: 31867057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease.
    Sinaga DA; Ho HH; Watson TJ; Sim A; Nyein TT; Jafary FH; Loh JK; Ooi YW; Tan JK; Ong PJ
    J Interv Cardiol; 2016 Oct; 29(5):454-460. PubMed ID: 27578540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.